Our Clinical Trials

  • ACCESS-AP: A Case-Crossover Study design to inform tailored interventions to prevent disease progression in Acute Pancreatitis
  • PAPPEI: Post-Acute Pancreatitis Pancreatic Exocrine Insufficiency
  • SVI: Stent vs. Indomethacin for Preventing Post-ERCP Pancreatitis
  • CalciMedica CM4620-203: Acute Pancreatitis Study
  • PROCEED: Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
  • SHARP: SpHincterotomy for Acute Recurrent Pancreatitis
  • POST: A Prospective Observational Study of TPIAT
  • DETECT: Evaluation of a mixed meal test for Diagnosis and characterization of Type 3c diabetes mellitus secondary to pancreatic cancer and chronic pancreatitis
  • CAMOSTAT: A phase ½ trial to evaluate the pharmacokinetics, safety and efficacy of NI-03 in patients with chronic pancreatitis
  • PAIR: Phase ½ trial of Indomethacin in Chronic Pancreatitis
  • CLIMB: Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
  • NANOPAC: Evaluation of Escalating Doses and the Safety of Intracystic Injection of NanoPac in Subjects with Cystic Pancreatic Neoplasms
  • Pancreatic Cystic Fluid Reference Set: Evaluation of molecular markers in pancreatic cysts
  • EQuiPP: Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis
  • Pancreatic disorder repository: Biobank specimen repository

Share this page